Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty
12/03/2025 23:35
March 12 (Reuters) - Heidelberg Pharma AG HPHA.DE: EQS-ADHOC: HEIDELBERG PHARMA AMENDS ROYALTY FINANCING WITH HEALTHCARE ROYALTY HEIDELBERG PHARMA AG - AGREEMENT PROVIDES FOR USD 20 MILLION PAYMENT HEIDELBERG PHARMA AG - EXTENDS CASH RUNWAY INTO 2027 Source text: ID:nEQ6RKV8Fa Further company coverage: HPHA.DE ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty